Drug Shortage Report for MYLAN-LANSOPRAZOLE

Last updated on 2018-08-15 History
Report ID 14700
Drug Identification Number 02353830
Brand name MYLAN-LANSOPRAZOLE
Common or Proper name LANSOPRAZOLE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) LANSOPRAZOLE
Strength(s) 15MG
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL
Packaging size 100BT
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-08-10
Actual start date 2018-08-07
Estimated end date 2018-08-30
Actual end date 2018-08-14
Shortage status Resolved
Updated date 2018-08-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v70 2018-08-15 French Compare
v69 2018-08-15 English Compare
v68 2018-08-08 French Compare
v67 2018-08-08 English Compare
v66 2018-08-01 French Compare
v65 2018-08-01 English Compare
v64 2018-07-31 French Compare
v63 2018-07-31 English Compare
v62 2018-04-24 French Compare
v61 2018-04-24 English Compare
v60 2018-04-16 French Compare
v59 2018-04-16 English Compare
v58 2018-04-13 French Compare
v57 2018-04-13 English Compare
v56 2018-04-02 French Compare
v55 2018-04-02 English Compare
v54 2018-03-09 French Compare
v53 2018-03-09 English Compare
v52 2018-02-27 French Compare
v51 2018-02-27 English Compare

Showing 1 to 20 of 70